The last day of operation for Hertfordshire and West Essex ICB was 31 March 2026. The information on this website has not been updated since 31 March 2026. The legacy policies, prescribing recommendations and pathways can be accessed on this website. Find out more

RAG rating
n/a
Document type
Clinical pathways
Place
Hertfordshire and West Essex ICB
Output type
Clinical Pathways
Pathway
Suspected Heart FailureHeart failure with reduced ejection fraction (HFrEF) in primary care (Confirmed) | Follow up pathway

Heart Failure

Pathway Publish Date: February 2024
Next Review Date: February 2026


  • Conduct cardio vascular examination, assess for red flags (see pathway)
  • Perform ECG
  • Take BNP/ pro-NT BNP
  • FBC, U&Es, LFTs, TFTs, HbA1c/glucose

The following patients should be referred to emergency care:

  • Acute pulmonary oedema
  • Symptoms and signs of heart failure associated with
    • Anginal chest pain at rest – suggestive of possible acute coronary syndrome (ACS)
    • Tachyarrhythmias
    • Syncope or pre-syncope
    • Severe fluid retention            
  • Heart failure with symptomatic hypotension and signs of hypoperfusion, e.g. cold peripheries, cyanosis, confusion

Suspected heart failure and previous myocardial infarction - refer to rapid access heart failure clinic

BNP/ pro-NT BNP normal - unlikely to be heart failure, consider differential diagnosis (see pathway)

Suspected heart failure and BNP >400 or Pro-NT BNP >2000 - refer to rapid access heart failure clinic

Suspected heart failure and BNP 100-400 or Pro-NT BNP 400-2000 - refer for direct access ECHO (available at the Lister.  NB: if direct access ECHO not available refer to heart failure clinic)

ECHO results:

  • Minor abnormality or normal ECHO - consider diferential diagnosis
  • Abnormal results follow instructions on interpretation guide

Consider referral for ongoing specialist advice:

  • For the management of:
    • Severe heart failure (New York Heart Association [NYHA] class II-IV)
    • Heart failure that does not respond to treatment in primary care or can no longer be managed in the home setting
    • Heart failure resulting from severe valvular heart disease
    • New left ventricular systolic impairment (ejection fraction of 45% or less)
  • If the patient is pregnant, or is planning a pregnancy
  • If the patient has certain co-morbidities (e.g. angina, renal impairment (e.g. Creatinine >200), anaemia, thyroid disease, asthma/COPD, gout, peripheral arterial disease, valve disease)
  • For consideration of CRT-D or ICD if:
    • LV ejection fraction  <35% and patient has had previous myocardial infarction; OR
    • NYHA Class III or IV symptoms and known left bundle branch block (LBBB) on ECG

Include in referral:

  • Type, onset and duration of symptoms
  • Past medical history including cardiac history
  • Examination findings- signs of heart failure and basic observations
  • BNP/pro-NT BNP levels
  • Routine bloods, including creatinine, thyroid function and blood glucose
  • ECG findings
  • Most recent ECHO findings 

Recommendations for management:

  • Stop contraindicated medicines including: NSAIDs and calcium-channel blockers
  • Consider a loop diuretic as symptom management. Titrate dose to control symptoms
  • Monitor urea and electrolytes at baseline and 1-2 weeks after medication initiation (or dose increase)
  • Monitor weight and hydration status

Patient information leaflet: Suspected Heart Failure

Back